The burgeoning field of metabolic management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://laraqnpg730718.prublogger.com/37677698/glp-3-receptor-agonists-retatrutide-trizepatide